iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Shares Sold by Pacific Sun Financial Corp

Pacific Sun Financial Corp lowered its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 2.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 8,754 shares of the financial services provider’s stock after selling 175 shares during the quarter. Pacific Sun Financial Corp’s holdings in iShares Nasdaq Biotechnology ETF were worth $871,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently added to or reduced their stakes in IBB. JPMorgan Chase & Co. grew its position in shares of iShares Nasdaq Biotechnology ETF by 120.0% during the second quarter. JPMorgan Chase & Co. now owns 1,108,069 shares of the financial services provider’s stock worth $118,874,000 after buying an additional 604,388 shares in the last quarter. Tibra Equities Europe Ltd bought a new position in iShares Nasdaq Biotechnology ETF during the second quarter worth $58,914,000. Natixis lifted its stake in iShares Nasdaq Biotechnology ETF by 66.7% during the second quarter. Natixis now owns 1,250,929 shares of the financial services provider’s stock worth $136,476,000 after purchasing an additional 500,326 shares during the last quarter. SG Americas Securities LLC bought a new position in iShares Nasdaq Biotechnology ETF during the second quarter worth $16,695,000. Finally, Voloridge Investment Management LLC bought a new position in iShares Nasdaq Biotechnology ETF during the second quarter worth $14,267,000. 79.34% of the stock is owned by institutional investors and hedge funds.

Separately, ValuEngine cut iShares Nasdaq Biotechnology ETF from a “buy” rating to a “hold” rating in a research note on Tuesday, October 22nd.

IBB traded up $2.01 during trading hours on Friday, hitting $110.36. 1,611,700 shares of the stock were exchanged, compared to its average volume of 2,375,580. The stock has a 50-day simple moving average of $103.43 and a 200-day simple moving average of $104.61. iShares Nasdaq Biotechnology ETF has a 12 month low of $89.01 and a 12 month high of $116.25.

iShares Nasdaq Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Story: What is a death cross?

Want to see what other hedge funds are holding IBB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB).

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.